Pharmacelera
Pharmacelera develops proprietary Computer-Aided Drug Design (CADD) software and provides computational chemistry services to enhance pharmaceutical R&D productivity. Their technology leverages Quantum Mechanics, Machine Learning, and High-Performance Computing, derived from over 25 years of research, to efficiently mine ultra-large chemical spaces and identify novel, diverse compounds. Pharmacelera assists clients in various drug discovery stages, including Target Identification, Hit Identification, Hit-to-Lead, and Lead Optimization, by finding new hits, improving ligand binding properties, and gaining insights into ligand-receptor interactions. Their software solutions like PharmScreen, exaScreen, and PharmQSAR enable exploration of larger chemical diversity and novel scaffolds, aiming to de-risk drug discovery projects for small biotech companies, big pharma, and research institutions.
Pharmacelera
Pharmacelera develops proprietary Computer-Aided Drug Design (CADD) software and provides computational chemistry services to enhance pharmaceutical R&D productivity. Their technology leverages Quantum Mechanics, Machine Learning, and High-Performance Computing, derived from over 25 years of research, to efficiently mine ultra-large chemical spaces and identify novel, diverse compounds. Pharmacelera assists clients in various drug discovery stages, including Target Identification, Hit Identification, Hit-to-Lead, and Lead Optimization, by finding new hits, improving ligand binding properties, and gaining insights into ligand-receptor interactions. Their software solutions like PharmScreen, exaScreen, and PharmQSAR enable exploration of larger chemical diversity and novel scaffolds, aiming to de-risk drug discovery projects for small biotech companies, big pharma, and research institutions.